Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetraxim vs DTaP + IPV in infants
NCT00319852Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2006
- Primary completion
- Apr 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diphtheria toxoid + tetanus toxoid + acellular pertussis in diphtheria, Tetanus, pertussis and 1 more, sponsored by Sanofi. Primary endpoint: Seroprotection Rate for Diphtheria. Started Apr 2006; status: completed.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on NCT00319852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319852.